Log in
(Ad)
Official tax return reveals how one trader nabbed annual gains of 228%, 309% and 339%. His tax return was released online, exposing this simple trading technique used to pocket nearly half a million in profits.

NASDAQ:LMNX - Luminex Stock Price, Forecast & News

$22.59
-0.54 (-2.33 %)
(As of 01/23/2020 08:16 AM ET)
Today's Range
$22.55
Now: $22.59
$23.28
50-Day Range
$20.44
MA: $22.52
$23.73
52-Week Range
$17.34
Now: $22.59
$28.33
Volume272,102 shs
Average Volume198,759 shs
Market Capitalization$1.02 billion
P/E RatioN/A
Dividend Yield1.56%
Beta0.84
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; and VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryLife Sciences Tools & Services
SectorMedical
Current SymbolNASDAQ:LMNX
CUSIP55027E10
Phone512-219-8020

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$315.82 million
Cash Flow$0.99 per share
Book Value$10.49 per share

Profitability

Net Income$18.51 million

Miscellaneous

Employees988
Market Cap$1.02 billion
Next Earnings Date2/10/2020 (Confirmed)
OptionableOptionable

Receive LMNX News and Ratings via Email

Sign-up to receive the latest news and ratings for LMNX and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

George Gilder has a shocking message for anybody with money in the bank, with a job that pays in dollars, or who carries a smartphone in their pocket. "Brace yourself," he says, "for the coming $16.8 trillion global 'reboot' ahead." It could change the way you get paid...change the way you save and invest for retirement.

Luminex (NASDAQ:LMNX) Frequently Asked Questions

What is Luminex's stock symbol?

Luminex trades on the NASDAQ under the ticker symbol "LMNX."

How often does Luminex pay dividends? What is the dividend yield for Luminex?

Luminex declared a quarterly dividend on Monday, December 9th. Shareholders of record on Thursday, December 19th will be paid a dividend of $0.09 per share on Wednesday, January 15th. This represents a $0.36 dividend on an annualized basis and a yield of 1.59%. The ex-dividend date is Wednesday, December 18th. View Luminex's Dividend History.

How were Luminex's earnings last quarter?

Luminex Co. (NASDAQ:LMNX) announced its quarterly earnings data on Monday, November, 4th. The medical instruments supplier reported ($0.12) EPS for the quarter, missing the Zacks' consensus estimate of ($0.07) by $0.05. The medical instruments supplier had revenue of $78.67 million for the quarter, compared to analyst estimates of $81.75 million. Luminex had a negative net margin of 2.93% and a negative return on equity of 2.38%. Luminex's revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.04 earnings per share. View Luminex's Earnings History.

When is Luminex's next earnings date?

Luminex is scheduled to release their next quarterly earnings announcement on Monday, February 10th 2020. View Earnings Estimates for Luminex.

How can I listen to Luminex's earnings call?

Luminex will be holding an earnings conference call on Monday, February 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for LMNX?

3 analysts have issued 12-month price targets for Luminex's shares. Their forecasts range from $21.00 to $32.00. On average, they anticipate Luminex's share price to reach $26.50 in the next twelve months. This suggests a possible upside of 17.3% from the stock's current price. View Analyst Price Targets for Luminex.

What is the consensus analysts' recommendation for Luminex?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Luminex in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Luminex.

Has Luminex been receiving favorable news coverage?

News articles about LMNX stock have been trending somewhat positive on Thursday, according to InfoTrie. The research firm ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Luminex earned a news impact score of 1.6 on InfoTrie's scale. They also gave press coverage about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Luminex.

Are investors shorting Luminex?

Luminex saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 1,070,000 shares, an increase of 8.7% from the December 15th total of 984,200 shares. Based on an average daily volume of 227,500 shares, the short-interest ratio is currently 4.7 days. Currently, 2.6% of the company's shares are sold short. View Luminex's Current Options Chain.

Who are some of Luminex's key competitors?

What other stocks do shareholders of Luminex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Luminex investors own include Baidu (BIDU), Micron Technology (MU), AbbVie (ABBV), Pfizer (PFE), Verizon Communications (VZ), Alphabet (GOOG), Starbucks (SBUX), AT&T (T), Exxon Mobil (XOM) and Nektar Therapeutics (NKTR).

Who are Luminex's key executives?

Luminex's management team includes the folowing people:
  • Mr. Nachum Shamir, CEO, Pres & Director (Age 65)
  • Mr. Harriss T. Currie, CFO, Sr. VP of Fin. & Treasurer (Age 57)
  • Mr. Richard W. Rew II, Sr. VP, Gen. Counsel & Corp. Sec. (Age 51)
  • Mr. Todd C. Bennett, Sr. VP of Global Sales & Customer Operations (Age 49)
  • Mr. Randall J. Myers, Sr. VP of Global Manufacturing & Quality (Age 57)

Who are Luminex's major shareholders?

Luminex's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Tocqueville Asset Management L.P. (0.14%), State of Alaska Department of Revenue (0.07%), Gibson Capital LLC (0.05%), Louisiana State Employees Retirement System (0.03%) and Nisa Investment Advisors LLC (0.02%). Company insiders that own Luminex stock include Charles J Collins, Eric Shapiro, G Walter Loewenbaum II, Nachum Shamir and Todd C Bennett. View Institutional Ownership Trends for Luminex.

Which major investors are selling Luminex stock?

LMNX stock was sold by a variety of institutional investors in the last quarter, including Nisa Investment Advisors LLC, Louisiana State Employees Retirement System and State of Alaska Department of Revenue. View Insider Buying and Selling for Luminex.

Which major investors are buying Luminex stock?

LMNX stock was purchased by a variety of institutional investors in the last quarter, including Gibson Capital LLC and Tocqueville Asset Management L.P.. Company insiders that have bought Luminex stock in the last two years include G Walter Loewenbaum II and Nachum Shamir. View Insider Buying and Selling for Luminex.

How do I buy shares of Luminex?

Shares of LMNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Luminex's stock price today?

One share of LMNX stock can currently be purchased for approximately $22.59.

How big of a company is Luminex?

Luminex has a market capitalization of $1.02 billion and generates $315.82 million in revenue each year. The medical instruments supplier earns $18.51 million in net income (profit) each year or $0.48 on an earnings per share basis. Luminex employs 988 workers across the globe.View Additional Information About Luminex.

What is Luminex's official website?

The official website for Luminex is http://www.luminexcorp.com/.

How can I contact Luminex?

Luminex's mailing address is 12212 TECHNOLOGY BLVD, AUSTIN TX, 78727. The medical instruments supplier can be reached via phone at 512-219-8020 or via email at [email protected]


MarketBeat Community Rating for Luminex (NASDAQ LMNX)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  238 (Vote Outperform)
Underperform Votes:  361 (Vote Underperform)
Total Votes:  599
MarketBeat's community ratings are surveys of what our community members think about Luminex and other stocks. Vote "Outperform" if you believe LMNX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LMNX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Featured Article: Profit Margin

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel